| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44e0905262f429c7590b40df8448c0c5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4891
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 |
| filingDate |
2014-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2111cadf6e48f81fa96e0efabcc72bd7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af5ce144e4faeb67b8726b99ed2718ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f787ce0ec22da779abee8163289eea0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf710f5fee0d49cc38217535ef8ea456 |
| publicationDate |
2018-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10154966-B2 |
| titleOfInvention |
Tamper-resistant dosage form containing one or more particles |
| abstract |
The invention relates to a tamper-resistant pharmaceutical dosage form comprising one or more particles, wherein each of said one or more particlesn comprises a pharmacologically active ingredient and a physiologically acceptable polymer; has a breaking strength of at least 300 N; has a weight of at least 2 mg; and optionally, comprises a film-coating;n nwherein the total weight of the pharmaceutical dosage form is greater than the total weight of said one or more particles. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10842750-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019142757-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10864164-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10729658-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020038330-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10675278-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10695297-B2 |
| priorityDate |
2013-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |